106 related articles for article (PubMed ID: 11414524)
61. Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010.
Chen PY; Chuang YC; Wang JT; Sheng WH; Yu CJ; Chu CC; Hsueh PR; Chang SC; Chen YC
J Microbiol Immunol Infect; 2014 Apr; 47(2):95-103. PubMed ID: 23063082
[TBL] [Abstract][Full Text] [Related]
62. Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010.
Chen CY; Huang SY; Tsay W; Yao M; Tang JL; Ko BS; Chou WC; Tien HF; Hsueh PR
Int J Antimicrob Agents; 2012 Dec; 40(6):533-8. PubMed ID: 23006521
[TBL] [Abstract][Full Text] [Related]
63. Association between incidence of candidaemia and consumption of antifungal agents at a medical centre in Taiwan.
Lai CC; Chu CC; Wang CY; Tsai HY; Cheng A; Lee YC; Huang YT; Liao CH; Hsueh PR
Int J Antimicrob Agents; 2012 Oct; 40(4):349-53. PubMed ID: 22819796
[TBL] [Abstract][Full Text] [Related]
64. Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome.
Chi HW; Yang YS; Shang ST; Chen KH; Yeh KM; Chang FY; Lin JC
J Microbiol Immunol Infect; 2011 Oct; 44(5):369-75. PubMed ID: 21524971
[TBL] [Abstract][Full Text] [Related]
65. Invasive candidiasis: an overview from Taiwan.
Ruan SY; Hsueh PR
J Formos Med Assoc; 2009 Jun; 108(6):443-51. PubMed ID: 19515624
[TBL] [Abstract][Full Text] [Related]
66. Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.
Hsueh PR; Graybill JR; Playford EG; Watcharananan SP; Oh MD; Ja'alam K; Huang S; Nangia V; Kurup A; Padiglione AA
Int J Antimicrob Agents; 2009 Sep; 34(3):205-9. PubMed ID: 19409759
[TBL] [Abstract][Full Text] [Related]
67. Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes.
Ruan SY; Huang YT; Chu CC; Yu CJ; Hsueh PR
Int J Antimicrob Agents; 2009 Sep; 34(3):236-9. PubMed ID: 19361960
[TBL] [Abstract][Full Text] [Related]
68. Adult candidemia at a medical center in northern Taiwan: a retrospective study.
Tsai CC; Wang CC; Kuo HY; Chiang DH; Lin ML; Liu CY; Yang SP
J Microbiol Immunol Infect; 2008 Oct; 41(5):414-21. PubMed ID: 19122924
[TBL] [Abstract][Full Text] [Related]
69. Community-onset candidemia at a university hospital, 1995-2005.
Kung HC; Wang JL; Chang SC; Wang JT; Sun HY; Hsueh PR; Chen YC
J Microbiol Immunol Infect; 2007 Aug; 40(4):355-63. PubMed ID: 17712471
[TBL] [Abstract][Full Text] [Related]
70. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
71. Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan.
Chen TC; Chen YH; Tsai JJ; Peng CF; Lu PL; Chang K; Hsieh HC; Chen TP
J Microbiol Immunol Infect; 2005 Jun; 38(3):200-10. PubMed ID: 15986071
[TBL] [Abstract][Full Text] [Related]
72. Bacteremia and fungemia in patients with advanced human immunodeficiency virus (HIV) infection in Taiwan.
Hung CC; Hsueh PR; Hsieh SM; Liu CJ; Chen MY; Luh KT
J Formos Med Assoc; 1998 Oct; 97(10):690-7. PubMed ID: 9830279
[TBL] [Abstract][Full Text] [Related]
73. Candidemia in the neonatal intensive care unit.
Shian WJ; Chi CS; Wang TM; Chen CH
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(5):349-55. PubMed ID: 8237353
[TBL] [Abstract][Full Text] [Related]
74. Antifungal Susceptibility and Clinical Outcome in Neonatal Candidiasis.
Autmizguine J; Tan S; Cohen-Wolkowiez M; Cotten CM; Wiederhold N; Goldberg RN; Adams-Chapman I; Stoll BJ; Smith PB; Benjamin DK;
Pediatr Infect Dis J; 2018 Sep; 37(9):923-929. PubMed ID: 29369937
[TBL] [Abstract][Full Text] [Related]
75. Old Cryptococcus neoformans cells contribute to virulence in chronic cryptococcosis.
Bouklas T; Pechuan X; Goldman DL; Edelman B; Bergman A; Fries BC
mBio; 2013 Aug; 4(4):. PubMed ID: 23943761
[TBL] [Abstract][Full Text] [Related]
76. Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants.
Wade KC; Benjamin DK; Kaufman DA; Ward RM; Smith PB; Jayaraman B; Adamson PC; Gastonguay MR; Barrett JS
Pediatr Infect Dis J; 2009 Aug; 28(8):717-23. PubMed ID: 19593252
[TBL] [Abstract][Full Text] [Related]
77. Antifungal agents in neonates: issues and recommendations.
Almirante B; RodrÃguez D
Paediatr Drugs; 2007; 9(5):311-21. PubMed ID: 17927303
[TBL] [Abstract][Full Text] [Related]
78. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates.
Roilides E; Farmaki E; Evdoridou J; Dotis J; Hatziioannidis E; Tsivitanidou M; Bibashi E; Filioti I; Sofianou D; Gil-Lamaignere C; Mueller FM; Kremenopoulos G
Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):745-50. PubMed ID: 15605181
[TBL] [Abstract][Full Text] [Related]
79. Antifungals in systemic neonatal candidiasis.
Frattarelli DA; Reed MD; Giacoia GP; Aranda JV
Drugs; 2004; 64(9):949-68. PubMed ID: 15101785
[TBL] [Abstract][Full Text] [Related]
80. Antifungal susceptibility testing and the correlation with clinical outcome in neonatal candidemia.
Huang YC; Kao HT; Lin TY; Kuo AJ
Am J Perinatol; 2001 May; 18(3):141-6. PubMed ID: 11414524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
